MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Comorbidities in Huntington’s disease: An Enroll-HD analysis

    J. Mills, J. Long, J. Vaidya, C. Sampaio, S. Sathe (Iowa City, USA)

    Objective: Determine the frequency of comorbidities in people with Huntington’s disease (PwHD) in comparison to non-carrier controls in the Enroll-HD cohort. Background: Despite some publications…
  • 2022 International Congress

    Diagnostic Utility of I123-FP-CIT Single Photon Emission Computed Tomography for Patients with Clinically Uncertain Parkinsonian Syndrome

    R. Falconer, T. Hunter, E. Szabo, C. Brand (Alexandria, USA)

    Objective: This study investigated the impact of I123-FP-CIT single photon emission computed tomography (SPECT) for the diagnosis of patients with clinically uncertain parkinsonian syndrome (CUPS)…
  • 2022 International Congress

    Non-dopaminergic system is related with motor reserve in Parkinson’s disease

    J. Youn, JH. Won, M. Kim, SH. Moon, M. Kim, JH. Ahn, YE. Huh, H. Park, JW. Cho (Seoul, Republic of Korea)

    Objective: To find related brain structures with the motor reserve in Parkinson's disease (PD). Background: There is a discrepancy between the severity of parkinsonism and dopaminergic…
  • 2022 International Congress

    Amantadine Is Effective Long-term in Parkinson’s Disease

    S. Park, BS. Jeon (Daejeon, Republic of Korea)

    Objective: This study aimed to investigate the long-term effectiveness of amantadine in patients with PD. Background: Amantadine has been used in the symptomatic treatment of…
  • 2022 International Congress

    Movement Disorders Associated With Vitamin B12 Deficiency: A Case Series

    R. Zouari, L. Hlioui, F. Nabli, MZ. Saeid, C. Jeridi, S. Blel, S. Ben Sassi (tunis, Tunisia)

    Objective: we present a case series of movement disorders (MD) due to vitamin B12 deficiency (VB12D) and compare them with the cases reported in the…
  • 2022 International Congress

    Effects of Subthalamic Nucleus Deep Brain Stimulation on pain in Parkinson disease: Real-life observational prospective study

    I. Carvalho, D. Damas, I. Cunha, S. Caldeira, P. Monteiro, R. Pereira, F. Moreira (Coimbra, Portugal)

    Objective: To evaluate the effect of subthalamic nucleus deep brain stimulation (STN-DBS) on the different characteristics of pain in patients with Parkinson disease (PD). Background:…
  • 2022 International Congress

    Post anoxic chorea: a rare complication after anoxic brain injury

    C. Wantaneeyawong, K. Thiankhaw (Chiang Mai, Thailand)

    Objective: To report a case of post anoxic chorea which is considered as a rare complication of post cardiac arrest. Background: Neurologic complication is a…
  • 2022 International Congress

    Unravelling Hidden Mutations Behind the Heterozygos SYNE1 Genotype

    Y. Salamatova, L. Terpak, E. Giatour, N. Shneyder (jacksonville, USA)

    Objective: To present case series of four patients of heterozygous for SYNE1 mutation with phenotype consistent with cerebellar ataxia. Background: Recessive cerebellar ataxias are defined as disorders with autosomal recessive…
  • 2022 International Congress

    Diagnostic yield for point mutation related SCAs through exome sequencing for undetermined ataxias

    JL. Pedroso, T. Silva, M. França Jr, O. Barsottini (São Paulo, Brazil)

    Objective: To describe the diagnostic yield of whole exome sequencing (WES) to identify autosomal dominant spinocerebellar ataxias (SCAs) caused by point mutations. Background: There are…
  • 2022 International Congress

    Outcome and mortality of hospital admission with COVID-19 in parkinsonian syndromes

    L. Sorrell, A. Barnett, A. King, J. Inches, J. Rideout, J. Sneyd, C. Kobylecki, K. Chaudhuri, R. Walker, H. Martin, K. Stevens, S. Campbell, C. Carroll (Plymouth, United Kingdom)

    Objective: To evaluate features associated with poor outcome and mortality of COVID-19 in people with Parkinson’s disease (PD) and atypical Parkinsonian syndromes (APS) in a…
  • « Previous Page
  • 1
  • …
  • 764
  • 765
  • 766
  • 767
  • 768
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley